Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Cash from Operations (Quarterly): -38.64M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -38.64M |
| June 30, 2024 | -49.17M |
| March 31, 2024 | -46.17M |
| December 31, 2023 | -47.12M |
| September 30, 2023 | -43.59M |
| June 30, 2023 | -48.59M |
| March 31, 2023 | -32.80M |
| December 31, 2022 | -28.59M |
| September 30, 2022 | -33.21M |
| June 30, 2022 | -33.46M |
| March 31, 2022 | -22.56M |
| December 31, 2021 | -18.35M |
| September 30, 2021 | -22.96M |
| June 30, 2021 | -18.31M |
| March 31, 2021 | -16.13M |
| Date | Value |
|---|---|
| December 31, 2020 | -12.99M |
| September 30, 2020 | -17.18M |
| June 30, 2020 | -15.09M |
| March 31, 2020 | -11.26M |
| December 31, 2019 | -15.74M |
| September 30, 2019 | -19.97M |
| June 30, 2019 | -13.58M |
| March 31, 2019 | -6.033M |
| December 31, 2018 | -6.103M |
| September 30, 2018 | -6.383M |
| June 30, 2018 | -6.859M |
| March 31, 2018 | -4.233M |
| December 31, 2017 | -2.695M |
| September 30, 2017 | -3.593M |
| June 30, 2017 | -5.493M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-49.17M
Minimum
Jun 2024
-11.26M
Maximum
Mar 2020
-28.59M
Average
-25.78M
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 5.591B |
| Nuvalent Inc | -45.82M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.458M |
| Cash from Financing (Quarterly) | -0.039M |
| Free Cash Flow | -188.31M |
| Free Cash Flow Per Share (Quarterly) | -0.5183 |
| Free Cash Flow Yield | -24.81% |